CA2675252C - N-substituted glycine derivatives: hydroxylase inhibitors - Google Patents
N-substituted glycine derivatives: hydroxylase inhibitors Download PDFInfo
- Publication number
- CA2675252C CA2675252C CA2675252A CA2675252A CA2675252C CA 2675252 C CA2675252 C CA 2675252C CA 2675252 A CA2675252 A CA 2675252A CA 2675252 A CA2675252 A CA 2675252A CA 2675252 C CA2675252 C CA 2675252C
- Authority
- CA
- Canada
- Prior art keywords
- oxo
- dihydro
- glycine
- hydroxy
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010049175 N-substituted Glycines Proteins 0.000 title abstract description 4
- 150000002332 glycine derivatives Chemical class 0.000 title abstract description 4
- 102000008109 Mixed Function Oxygenases Human genes 0.000 title description 3
- 108010074633 Mixed Function Oxygenases Proteins 0.000 title description 3
- 239000003112 inhibitor Substances 0.000 title description 3
- 208000007502 anemia Diseases 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims description 425
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 162
- 230000002829 reductive effect Effects 0.000 claims description 116
- -1 5-hydroxy-6-(1-methylethyl)-3-oxo-2-{[4'-(trifluoromethyl)-2-biphenylyl]methyl}-2,3-dihydro-4-pyridazinyl Chemical group 0.000 claims description 59
- 150000003839 salts Chemical class 0.000 claims description 31
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 21
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims description 15
- WVQKWBBINAVAHK-UHFFFAOYSA-N 2-[[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(Br)C=C1F WVQKWBBINAVAHK-UHFFFAOYSA-N 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- BPFLAJJDOYQJEP-UHFFFAOYSA-N 2-[[2-[(4-bromophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(Br)C=C1 BPFLAJJDOYQJEP-UHFFFAOYSA-N 0.000 claims description 9
- VDVLEQVPLSQREQ-UHFFFAOYSA-N 2-[[2-[(2-bromophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1Br VDVLEQVPLSQREQ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003085 diluting agent Substances 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 102000003951 Erythropoietin Human genes 0.000 claims description 5
- 108090000394 Erythropoietin Proteins 0.000 claims description 5
- 229940105423 erythropoietin Drugs 0.000 claims description 5
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 5
- IMQPYVPFWOAQOP-UHFFFAOYSA-N 2-[[2-[(3-bromophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC(Br)=C1 IMQPYVPFWOAQOP-UHFFFAOYSA-N 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- CASXZMAHBJFQIZ-UHFFFAOYSA-N 2-[[2-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C(F)(F)F)C=C1F CASXZMAHBJFQIZ-UHFFFAOYSA-N 0.000 claims description 3
- ULIQJGDMWQPTAA-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[2-(4-nitrophenyl)phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=C([N+]([O-])=O)C=C1 ULIQJGDMWQPTAA-UHFFFAOYSA-N 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- UZNSRZNFJZBRFE-UHFFFAOYSA-N 2-[(4-hydroxy-6-oxo-3-propan-2-yl-1h-pyridazine-5-carbonyl)amino]acetic acid Chemical compound CC(C)C1=NNC(=O)C(C(=O)NCC(O)=O)=C1O UZNSRZNFJZBRFE-UHFFFAOYSA-N 0.000 claims description 2
- IXOWKENJMBHUQM-UHFFFAOYSA-N 2-[(4-hydroxy-6-oxo-3-thiophen-2-yl-1h-pyridazine-5-carbonyl)amino]acetic acid Chemical compound N1C(=O)C(C(=O)NCC(=O)O)=C(O)C(C=2SC=CC=2)=N1 IXOWKENJMBHUQM-UHFFFAOYSA-N 0.000 claims description 2
- WEWQENZTNCDJGM-UHFFFAOYSA-N 2-[[2-[(4-tert-butylphenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C(C)(C)C)C=C1 WEWQENZTNCDJGM-UHFFFAOYSA-N 0.000 claims description 2
- DHGSJWBFHVGHDG-UHFFFAOYSA-N 2-[[2-[[2-(4-aminophenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=C(N)C=C1 DHGSJWBFHVGHDG-UHFFFAOYSA-N 0.000 claims description 2
- WSVNXZBCYPWRCQ-UHFFFAOYSA-N 2-[[2-[[2-(4-fluorophenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=C(F)C=C1 WSVNXZBCYPWRCQ-UHFFFAOYSA-N 0.000 claims description 2
- UDOJUYSSRYDBNP-UHFFFAOYSA-N 2-[[2-[[4-(2,6-difluoropyridin-4-yl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=C(F)N=C(F)C=2)C=C1 UDOJUYSSRYDBNP-UHFFFAOYSA-N 0.000 claims description 2
- NQGJCFFOVIOINF-UHFFFAOYSA-N 2-[[4-hydroxy-3-(1H-indol-3-yl)-6-oxo-1H-pyridazine-5-carbonyl]amino]acetic acid Chemical compound N1C(=O)C(C(=O)NCC(=O)O)=C(O)C(C=2C3=CC=CC=C3NC=2)=N1 NQGJCFFOVIOINF-UHFFFAOYSA-N 0.000 claims description 2
- AHVSZWUPCCNAOZ-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[2-(2-methoxyphenyl)phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound COC1=CC=CC=C1C1=CC=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=N1 AHVSZWUPCCNAOZ-UHFFFAOYSA-N 0.000 claims description 2
- USQQRSHNDHDDAD-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-2-[[3-(2-piperazin-1-ylpyridin-4-yl)phenyl]methyl]-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC(C=2C=C(N=CC=2)N2CCNCC2)=C1 USQQRSHNDHDDAD-UHFFFAOYSA-N 0.000 claims description 2
- JWXMUUZCFGXCRK-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-2-[[4-(2-piperazin-1-ylpyridin-4-yl)phenyl]methyl]-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=C(N=CC=2)N2CCNCC2)C=C1 JWXMUUZCFGXCRK-UHFFFAOYSA-N 0.000 claims description 2
- FIQFORZVCULREV-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-6-propan-2-yl-2-(2,2,2-trifluoroethyl)pyridazine-4-carbonyl]amino]acetic acid Chemical compound CC(C)C1=NN(CC(F)(F)F)C(=O)C(C(=O)NCC(O)=O)=C1O FIQFORZVCULREV-UHFFFAOYSA-N 0.000 claims description 2
- ZHIDTPLDXKHNAO-UHFFFAOYSA-N 4-[2-[[5-(carboxymethylcarbamoyl)-4-hydroxy-6-oxo-3-propan-2-ylpyridazin-1-yl]methyl]phenyl]benzoic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=C(C(O)=O)C=C1 ZHIDTPLDXKHNAO-UHFFFAOYSA-N 0.000 claims description 2
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 238000002512 chemotherapy Methods 0.000 claims description 2
- 208000017169 kidney disease Diseases 0.000 claims description 2
- VPFOQJUBBWBKME-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-6-propan-2-yl-2-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C(F)(F)F VPFOQJUBBWBKME-UHFFFAOYSA-N 0.000 claims 3
- FSRJQICLTPDNNW-UHFFFAOYSA-N 2-[(2,6-dicyclohexyl-5-hydroxy-3-oxopyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C2CCCCC2)=NN1C1CCCCC1 FSRJQICLTPDNNW-UHFFFAOYSA-N 0.000 claims 1
- DWRGIUZLXHTJKW-UHFFFAOYSA-N 2-[(2-benzyl-5-hydroxy-3-oxo-6-phenylpyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC=CC=2)=NN1CC1=CC=CC=C1 DWRGIUZLXHTJKW-UHFFFAOYSA-N 0.000 claims 1
- MTJZXXIGRIUJEU-UHFFFAOYSA-N 2-[(2-benzyl-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1 MTJZXXIGRIUJEU-UHFFFAOYSA-N 0.000 claims 1
- RTRPUIOGIULCPA-UHFFFAOYSA-N 2-[(2-benzyl-5-hydroxy-6-methyl-3-oxopyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C)=NN1CC1=CC=CC=C1 RTRPUIOGIULCPA-UHFFFAOYSA-N 0.000 claims 1
- CYTOEKGIWACJBC-UHFFFAOYSA-N 2-[(2-benzyl-6-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C2CCCCC2)=NN1CC1=CC=CC=C1 CYTOEKGIWACJBC-UHFFFAOYSA-N 0.000 claims 1
- YIHUTURCVOVYCS-UHFFFAOYSA-N 2-[(2-cyclohexyl-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1C1CCCCC1 YIHUTURCVOVYCS-UHFFFAOYSA-N 0.000 claims 1
- VMQYMEKAPSRKMX-UHFFFAOYSA-N 2-[(4-hydroxy-6-oxo-3-phenyl-1h-pyridazine-5-carbonyl)amino]acetic acid Chemical compound N1C(=O)C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC=CC=2)=N1 VMQYMEKAPSRKMX-UHFFFAOYSA-N 0.000 claims 1
- WRENSAXIPQHRGH-UHFFFAOYSA-N 2-[(6-tert-butyl-2-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carbonyl)amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=NN1C1CCCCC1 WRENSAXIPQHRGH-UHFFFAOYSA-N 0.000 claims 1
- JSKPGEWZEVXBIQ-UHFFFAOYSA-N 2-[[2-(1,3-benzothiazol-2-ylmethyl)-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=NC2=CC=CC=C2S1 JSKPGEWZEVXBIQ-UHFFFAOYSA-N 0.000 claims 1
- FNSMXFOXZPNJEP-UHFFFAOYSA-N 2-[[2-(2-cyclopropylethyl)-5-hydroxy-3-oxo-6-phenylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC=CC=2)=NN1CCC1CC1 FNSMXFOXZPNJEP-UHFFFAOYSA-N 0.000 claims 1
- OAQITUIZGBKVMW-UHFFFAOYSA-N 2-[[2-(2-cyclopropylethyl)-6-(4-fluorophenyl)-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(F)=CC=2)=NN1CCC1CC1 OAQITUIZGBKVMW-UHFFFAOYSA-N 0.000 claims 1
- VATJURRVWIQIFS-UHFFFAOYSA-N 2-[[2-[(2,3-dichlorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC(Cl)=C1Cl VATJURRVWIQIFS-UHFFFAOYSA-N 0.000 claims 1
- RIBZNDZJFDETRR-UHFFFAOYSA-N 2-[[2-[(2,4-dichlorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(Cl)C=C1Cl RIBZNDZJFDETRR-UHFFFAOYSA-N 0.000 claims 1
- WXFLMBUHZVVLLF-UHFFFAOYSA-N 2-[[2-[(2,4-difluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(F)C=C1F WXFLMBUHZVVLLF-UHFFFAOYSA-N 0.000 claims 1
- UPUDUHZONJHELB-UHFFFAOYSA-N 2-[[2-[(2,5-dichlorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC(Cl)=CC=C1Cl UPUDUHZONJHELB-UHFFFAOYSA-N 0.000 claims 1
- UQNTWXHNXDNIIM-UHFFFAOYSA-N 2-[[2-[(2,5-difluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC(F)=CC=C1F UQNTWXHNXDNIIM-UHFFFAOYSA-N 0.000 claims 1
- XOXTVUWGCFOAAS-UHFFFAOYSA-N 2-[[2-[(2,6-dichlorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=C(Cl)C=CC=C1Cl XOXTVUWGCFOAAS-UHFFFAOYSA-N 0.000 claims 1
- DPECEEYIAVHSFA-UHFFFAOYSA-N 2-[[2-[(2-bromophenyl)methyl]-6-tert-butyl-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=NN1CC1=CC=CC=C1Br DPECEEYIAVHSFA-UHFFFAOYSA-N 0.000 claims 1
- CEPMEUXTVODSRT-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxo-6-phenylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC=CC=2)=NN1CC1=CC=CC=C1Cl CEPMEUXTVODSRT-UHFFFAOYSA-N 0.000 claims 1
- CVNGAKQDKQVZRD-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1Cl CVNGAKQDKQVZRD-UHFFFAOYSA-N 0.000 claims 1
- NFYPEYAMAKLRIX-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-5-hydroxy-6-(2-methoxyphenyl)-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound COC1=CC=CC=C1C(C(=C(C(=O)NCC(O)=O)C1=O)O)=NN1CC1=CC=CC=C1Cl NFYPEYAMAKLRIX-UHFFFAOYSA-N 0.000 claims 1
- ZBGRVTLAEJZBDF-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-5-hydroxy-6-(3-methoxyphenyl)-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound COC1=CC=CC(C=2C(=C(C(=O)NCC(O)=O)C(=O)N(CC=3C(=CC=CC=3)Cl)N=2)O)=C1 ZBGRVTLAEJZBDF-UHFFFAOYSA-N 0.000 claims 1
- YRXKJIUJOBYNPS-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-5-hydroxy-6-(4-methoxyphenyl)-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(OC)=CC=C1C(C(=C(C(=O)NCC(O)=O)C1=O)O)=NN1CC1=CC=CC=C1Cl YRXKJIUJOBYNPS-UHFFFAOYSA-N 0.000 claims 1
- HXTBLOTWPWBPDA-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-6-(3,5-difluorophenyl)-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=C(F)C=C(F)C=2)=NN1CC1=CC=CC=C1Cl HXTBLOTWPWBPDA-UHFFFAOYSA-N 0.000 claims 1
- QALMZSSAQWCPGY-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-6-(3-ethoxy-5-fluorophenyl)-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound CCOC1=CC(F)=CC(C=2C(=C(C(=O)NCC(O)=O)C(=O)N(CC=3C(=CC=CC=3)Cl)N=2)O)=C1 QALMZSSAQWCPGY-UHFFFAOYSA-N 0.000 claims 1
- CQXIPEGUONYWOK-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-6-(4-fluorophenyl)-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(F)=CC=2)=NN1CC1=CC=CC=C1Cl CQXIPEGUONYWOK-UHFFFAOYSA-N 0.000 claims 1
- KDXBFIQIWOGQMC-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-6-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C2CCCCC2)=NN1CC1=CC=CC=C1Cl KDXBFIQIWOGQMC-UHFFFAOYSA-N 0.000 claims 1
- UCPFRQPQNFCCNE-UHFFFAOYSA-N 2-[[2-[(2-chlorophenyl)methyl]-6-ethoxycarbonyl-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(=O)OCC)=NN1CC1=CC=CC=C1Cl UCPFRQPQNFCCNE-UHFFFAOYSA-N 0.000 claims 1
- QPJVOFPLYJJKLN-UHFFFAOYSA-N 2-[[2-[(2-fluoro-4-phenylphenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC=CC=2)C=C1F QPJVOFPLYJJKLN-UHFFFAOYSA-N 0.000 claims 1
- ROWJQKRIMLNZTO-UHFFFAOYSA-N 2-[[2-[(2-fluoro-4-pyridin-4-ylphenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CN=CC=2)C=C1F ROWJQKRIMLNZTO-UHFFFAOYSA-N 0.000 claims 1
- HAWXRUHIBMESDD-UHFFFAOYSA-N 2-[[2-[(2-fluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1F HAWXRUHIBMESDD-UHFFFAOYSA-N 0.000 claims 1
- OSZRGJFOZFQCGY-UHFFFAOYSA-N 2-[[2-[(3,4-dichlorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(Cl)C(Cl)=C1 OSZRGJFOZFQCGY-UHFFFAOYSA-N 0.000 claims 1
- GNYGLNZSICUEPB-UHFFFAOYSA-N 2-[[2-[(3,5-difluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC(F)=CC(F)=C1 GNYGLNZSICUEPB-UHFFFAOYSA-N 0.000 claims 1
- AXLUPMJTRCEQMS-UHFFFAOYSA-N 2-[[2-[(3,5-difluorophenyl)methyl]-5-hydroxy-6-(4-hydroxyphenyl)-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(O)=CC=2)=NN1CC1=CC(F)=CC(F)=C1 AXLUPMJTRCEQMS-UHFFFAOYSA-N 0.000 claims 1
- HVQJZSNEZTUJEM-UHFFFAOYSA-N 2-[[2-[(3,5-difluorophenyl)methyl]-5-hydroxy-6-(4-methoxyphenyl)-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(OC)=CC=C1C(C(=C(C(=O)NCC(O)=O)C1=O)O)=NN1CC1=CC(F)=CC(F)=C1 HVQJZSNEZTUJEM-UHFFFAOYSA-N 0.000 claims 1
- ROFGRXZLIAMOFL-UHFFFAOYSA-N 2-[[2-[(3-cyanophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC(C#N)=C1 ROFGRXZLIAMOFL-UHFFFAOYSA-N 0.000 claims 1
- SVPMYXFTQALQCU-UHFFFAOYSA-N 2-[[2-[(4-chloro-2-fluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(Cl)C=C1F SVPMYXFTQALQCU-UHFFFAOYSA-N 0.000 claims 1
- KJJHZZOHCGGINO-UHFFFAOYSA-N 2-[[2-[(4-fluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(F)C=C1 KJJHZZOHCGGINO-UHFFFAOYSA-N 0.000 claims 1
- IUFALRYLFLZYJR-UHFFFAOYSA-N 2-[[2-[(4-tert-butylphenyl)methyl]-5-hydroxy-3-oxo-6-phenylpyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C=2C=CC=CC=2)=N1 IUFALRYLFLZYJR-UHFFFAOYSA-N 0.000 claims 1
- LLBJXUHJYDBXSZ-UHFFFAOYSA-N 2-[[2-[(4-tert-butylphenyl)methyl]-6-(4-chlorophenyl)-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C=2C=CC(Cl)=CC=2)=N1 LLBJXUHJYDBXSZ-UHFFFAOYSA-N 0.000 claims 1
- JBVRDBFRATUHDD-UHFFFAOYSA-N 2-[[2-[(4-tert-butylphenyl)methyl]-6-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C2CCCCC2)=N1 JBVRDBFRATUHDD-UHFFFAOYSA-N 0.000 claims 1
- HOFQOZPOIRYDEZ-UHFFFAOYSA-N 2-[[2-[[2-fluoro-4-(2-methoxyphenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound COC1=CC=CC=C1C(C=C1F)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=N1 HOFQOZPOIRYDEZ-UHFFFAOYSA-N 0.000 claims 1
- NEBHEVFCQFNITG-UHFFFAOYSA-N 2-[[2-[[2-fluoro-4-(4-fluorophenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(F)=CC=2)C=C1F NEBHEVFCQFNITG-UHFFFAOYSA-N 0.000 claims 1
- MITMXURVZBZLNX-UHFFFAOYSA-N 2-[[2-[[2-fluoro-4-(4-methylsulfanylphenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(SC)=CC=C1C(C=C1F)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=N1 MITMXURVZBZLNX-UHFFFAOYSA-N 0.000 claims 1
- QBYVUMGLQABSAD-UHFFFAOYSA-N 2-[[2-[[2-fluoro-4-(4-nitrophenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=C1F QBYVUMGLQABSAD-UHFFFAOYSA-N 0.000 claims 1
- SZKPZWMBMGCDDY-UHFFFAOYSA-N 2-[[2-[[2-fluoro-4-[4-(trifluoromethyl)phenyl]phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(=CC=2)C(F)(F)F)C=C1F SZKPZWMBMGCDDY-UHFFFAOYSA-N 0.000 claims 1
- WEYGUQCGUQEXPD-UHFFFAOYSA-N 2-[[2-[[4-(4-fluorophenyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(F)=CC=2)C=C1 WEYGUQCGUQEXPD-UHFFFAOYSA-N 0.000 claims 1
- INCXVGPAXTUQID-UHFFFAOYSA-N 2-[[2-benzyl-5-hydroxy-3-oxo-6-(trifluoromethyl)pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C(F)(F)F)=NN1CC1=CC=CC=C1 INCXVGPAXTUQID-UHFFFAOYSA-N 0.000 claims 1
- PBPXHPGOPGLQCP-UHFFFAOYSA-N 2-[[5-hydroxy-2-[(2-nitrophenyl)methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1[N+]([O-])=O PBPXHPGOPGLQCP-UHFFFAOYSA-N 0.000 claims 1
- HCDAUFAKGYNIRH-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[3-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC(C=2C=NC(=CC=2)N2CCN(C)CC2)=C1 HCDAUFAKGYNIRH-UHFFFAOYSA-N 0.000 claims 1
- ZVPVOVAZTUWNQD-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[4-(2-methoxyphenyl)phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound COC1=CC=CC=C1C(C=C1)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=N1 ZVPVOVAZTUWNQD-UHFFFAOYSA-N 0.000 claims 1
- NLEDBOJPZUGKKW-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[4-(2-methoxypyridin-4-yl)phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=NC(OC)=CC(C=2C=CC(CN3C(C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=N3)=O)=CC=2)=C1 NLEDBOJPZUGKKW-UHFFFAOYSA-N 0.000 claims 1
- HEWKEZWYAMOPPW-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[4-(4-nitrophenyl)phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=C1 HEWKEZWYAMOPPW-UHFFFAOYSA-N 0.000 claims 1
- YACWBZCPKGSXSL-UHFFFAOYSA-N 2-[[5-hydroxy-2-[[4-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]phenyl]methyl]-3-oxo-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=NC(=CC=2)N2CCN(C)CC2)C=C1 YACWBZCPKGSXSL-UHFFFAOYSA-N 0.000 claims 1
- RWILEBQJSWJTJX-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-2-[(2-phenylphenyl)methyl]-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=CC=C1 RWILEBQJSWJTJX-UHFFFAOYSA-N 0.000 claims 1
- NSFWBMSBBUIWNN-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-2-[(3-phenylphenyl)methyl]-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC(C=2C=CC=CC=2)=C1 NSFWBMSBBUIWNN-UHFFFAOYSA-N 0.000 claims 1
- NUMRUIPXEHYXLX-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-2-[(4-phenylphenyl)methyl]-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC=CC=2)C=C1 NUMRUIPXEHYXLX-UHFFFAOYSA-N 0.000 claims 1
- SQXILEOCASCMHB-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-2-[[2-(2-piperazin-1-ylpyridin-4-yl)phenyl]methyl]-6-propan-2-ylpyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=NC(N2CCNCC2)=C1 SQXILEOCASCMHB-UHFFFAOYSA-N 0.000 claims 1
- UIKSNTQBBOLXKX-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-6-phenyl-2-(2-phenylethyl)pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC=CC=2)=NN1CCC1=CC=CC=C1 UIKSNTQBBOLXKX-UHFFFAOYSA-N 0.000 claims 1
- HGYSLVHGPRECQQ-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-6-propan-2-yl-2-[(4-pyridin-4-ylphenyl)methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CN=CC=2)C=C1 HGYSLVHGPRECQQ-UHFFFAOYSA-N 0.000 claims 1
- DNILJPWLAZDBEN-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-6-propan-2-yl-2-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(=CC=2)C(F)(F)F)C=C1 DNILJPWLAZDBEN-UHFFFAOYSA-N 0.000 claims 1
- LYUMRFNFYTZTOG-UHFFFAOYSA-N 2-[[5-hydroxy-6-(3-methoxyphenyl)-3-oxo-2-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound COC1=CC=CC(C=2C(=C(C(=O)NCC(O)=O)C(=O)N(CC=3C(=CC=CC=3)C(F)(F)F)N=2)O)=C1 LYUMRFNFYTZTOG-UHFFFAOYSA-N 0.000 claims 1
- JSVCSRRGEWVMFF-UHFFFAOYSA-N 2-[[5-hydroxy-6-methyl-2-[(2-nitrophenyl)methyl]-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C)=NN1CC1=CC=CC=C1[N+]([O-])=O JSVCSRRGEWVMFF-UHFFFAOYSA-N 0.000 claims 1
- AYUVJBXEYBOKJO-UHFFFAOYSA-N 2-[[6-(3,5-difluorophenyl)-2-[(3,5-difluorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=C(F)C=C(F)C=2)=NN1CC1=CC(F)=CC(F)=C1 AYUVJBXEYBOKJO-UHFFFAOYSA-N 0.000 claims 1
- FLEMSODDMUWMIV-UHFFFAOYSA-N 2-[[6-(3,5-difluorophenyl)-5-hydroxy-3-oxo-2-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=C(F)C=C(F)C=2)=NN1CC1=CC=CC=C1C(F)(F)F FLEMSODDMUWMIV-UHFFFAOYSA-N 0.000 claims 1
- BPSMCHLWRRUVDB-UHFFFAOYSA-N 2-[[6-(3-ethoxy-5-fluorophenyl)-5-hydroxy-3-oxo-2-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound CCOC1=CC(F)=CC(C=2C(=C(C(=O)NCC(O)=O)C(=O)N(CC=3C(=CC=CC=3)C(F)(F)F)N=2)O)=C1 BPSMCHLWRRUVDB-UHFFFAOYSA-N 0.000 claims 1
- UBANCGSFTUWFEA-UHFFFAOYSA-N 2-[[6-(4-chlorophenyl)-2-(2-cyclohexylethyl)-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(Cl)=CC=2)=NN1CCC1CCCCC1 UBANCGSFTUWFEA-UHFFFAOYSA-N 0.000 claims 1
- HEOPFJSSSOIAQA-UHFFFAOYSA-N 2-[[6-(4-chlorophenyl)-2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(Cl)=CC=2)=NN1CC1=CC=CC=C1Cl HEOPFJSSSOIAQA-UHFFFAOYSA-N 0.000 claims 1
- USBXANXWQJMVBP-UHFFFAOYSA-N 2-[[6-(4-chlorophenyl)-5-hydroxy-3-oxo-2-[(4-phenylphenyl)methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(Cl)=CC=2)=NN1CC(C=C1)=CC=C1C1=CC=CC=C1 USBXANXWQJMVBP-UHFFFAOYSA-N 0.000 claims 1
- QIFUJJUUMQMROD-UHFFFAOYSA-N 2-[[6-(4-fluorophenyl)-5-hydroxy-3-oxo-2-[(4-phenylphenyl)methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(F)=CC=2)=NN1CC(C=C1)=CC=C1C1=CC=CC=C1 QIFUJJUUMQMROD-UHFFFAOYSA-N 0.000 claims 1
- KTHXHKBAWDUYPD-UHFFFAOYSA-N 2-[[6-(4-fluorophenyl)-5-hydroxy-3-oxo-2-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C=2C=CC(F)=CC=2)=NN1CC1=CC=CC=C1C(F)(F)F KTHXHKBAWDUYPD-UHFFFAOYSA-N 0.000 claims 1
- TWHSCALBXUJRDM-UHFFFAOYSA-N 2-[[6-(4-tert-butylphenyl)-2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C(=C(C(=O)NCC(O)=O)C1=O)O)=NN1CC1=CC=CC=C1Cl TWHSCALBXUJRDM-UHFFFAOYSA-N 0.000 claims 1
- XGBCYWXYLYOWCZ-UHFFFAOYSA-N 2-[[6-(4-tert-butylphenyl)-2-[(4-tert-butylphenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C=2C=CC(=CC=2)C(C)(C)C)=N1 XGBCYWXYLYOWCZ-UHFFFAOYSA-N 0.000 claims 1
- BMEBRCIDAGDITE-UHFFFAOYSA-N 2-[[6-(carboxymethylcarbamoyl)-2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(=O)NCC(=O)O)=NN1CC1=CC=CC=C1Cl BMEBRCIDAGDITE-UHFFFAOYSA-N 0.000 claims 1
- FUCTWSURKQZKDZ-UHFFFAOYSA-N 2-[[6-cyclohexyl-2-[(2-fluorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C2CCCCC2)=NN1CC1=CC=CC=C1F FUCTWSURKQZKDZ-UHFFFAOYSA-N 0.000 claims 1
- JPYQJCCMTICYIN-UHFFFAOYSA-N 2-[[6-cyclohexyl-2-[(3,4-dichlorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C2CCCCC2)=NN1CC1=CC=C(Cl)C(Cl)=C1 JPYQJCCMTICYIN-UHFFFAOYSA-N 0.000 claims 1
- PYFJJMYGWHYEDN-UHFFFAOYSA-N 2-[[6-cyclohexyl-5-hydroxy-2-[(2-methylphenyl)methyl]-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound CC1=CC=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C2CCCCC2)=N1 PYFJJMYGWHYEDN-UHFFFAOYSA-N 0.000 claims 1
- WNGPVZZKZCKQPA-UHFFFAOYSA-N 2-[[6-cyclohexyl-5-hydroxy-3-oxo-2-[[4-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(=O)O)=C(O)C(C2CCCCC2)=NN1CC1=CC=C(C(F)(F)F)C=C1 WNGPVZZKZCKQPA-UHFFFAOYSA-N 0.000 claims 1
- ROHKSWLTFYLFNN-UHFFFAOYSA-N 2-[[6-tert-butyl-2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=NN1CC1=CC=CC=C1Cl ROHKSWLTFYLFNN-UHFFFAOYSA-N 0.000 claims 1
- KEDPKFICQKJOMX-UHFFFAOYSA-N 2-[[6-tert-butyl-2-[(4-tert-butylphenyl)methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=N1 KEDPKFICQKJOMX-UHFFFAOYSA-N 0.000 claims 1
- HEQVJVMKSFUIGL-UHFFFAOYSA-N 2-[[6-tert-butyl-2-[[4-fluoro-2-(trifluoromethyl)phenyl]methyl]-5-hydroxy-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=NN1CC1=CC=C(F)C=C1C(F)(F)F HEQVJVMKSFUIGL-UHFFFAOYSA-N 0.000 claims 1
- ULADJBQSYOSSEY-UHFFFAOYSA-N 2-[[6-tert-butyl-5-hydroxy-2-[(2-methylphenyl)methyl]-3-oxopyridazine-4-carbonyl]amino]acetic acid Chemical compound CC1=CC=CC=C1CN1C(=O)C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=N1 ULADJBQSYOSSEY-UHFFFAOYSA-N 0.000 claims 1
- LSEXHEQPSGFBPE-UHFFFAOYSA-N 2-[[6-tert-butyl-5-hydroxy-3-oxo-2-[(4-phenylphenyl)methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=NN1CC1=CC=C(C=2C=CC=CC=2)C=C1 LSEXHEQPSGFBPE-UHFFFAOYSA-N 0.000 claims 1
- JURQMGLGXUDLDB-UHFFFAOYSA-N 2-[[6-tert-butyl-5-hydroxy-3-oxo-2-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)(C)C)=NN1CC1=CC=CC=C1C(F)(F)F JURQMGLGXUDLDB-UHFFFAOYSA-N 0.000 claims 1
- MABLLQQYHPWSQE-UHFFFAOYSA-N 4-[4-[[5-(carboxymethylcarbamoyl)-4-hydroxy-6-oxo-3-propan-2-ylpyridazin-1-yl]methyl]-3-fluorophenyl]benzoic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=C(C=2C=CC(=CC=2)C(O)=O)C=C1F MABLLQQYHPWSQE-UHFFFAOYSA-N 0.000 claims 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 claims 1
- 108010043005 Prolyl Hydroxylases Proteins 0.000 abstract description 13
- 102000004079 Prolyl Hydroxylases Human genes 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 239000005557 antagonist Substances 0.000 abstract 1
- MYKHANQTTIRZJK-UHFFFAOYSA-N pyridazine-3,4-dione Chemical compound O=C1C=CN=NC1=O MYKHANQTTIRZJK-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 581
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 378
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 328
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 321
- 238000006243 chemical reaction Methods 0.000 description 310
- 239000000243 solution Substances 0.000 description 295
- 235000019439 ethyl acetate Nutrition 0.000 description 255
- 239000000047 product Substances 0.000 description 217
- 238000005160 1H NMR spectroscopy Methods 0.000 description 199
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 168
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 149
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 138
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 136
- 239000000203 mixture Substances 0.000 description 135
- 239000007787 solid Substances 0.000 description 129
- 239000010410 layer Substances 0.000 description 120
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 117
- 239000004471 Glycine Substances 0.000 description 115
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 102
- 238000010992 reflux Methods 0.000 description 100
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 95
- 239000012267 brine Substances 0.000 description 92
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 92
- 239000012044 organic layer Substances 0.000 description 83
- WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 80
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 76
- 235000019341 magnesium sulphate Nutrition 0.000 description 74
- 229910000104 sodium hydride Inorganic materials 0.000 description 74
- 238000004440 column chromatography Methods 0.000 description 73
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 70
- 239000012312 sodium hydride Substances 0.000 description 70
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 69
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 65
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 65
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 58
- 229910052757 nitrogen Inorganic materials 0.000 description 57
- 239000002904 solvent Substances 0.000 description 57
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 56
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 56
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 53
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 51
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 50
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 49
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 45
- 239000000843 powder Substances 0.000 description 42
- 239000011541 reaction mixture Substances 0.000 description 41
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 35
- 238000004128 high performance liquid chromatography Methods 0.000 description 35
- 239000000377 silicon dioxide Substances 0.000 description 33
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 32
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 32
- 125000001072 heteroaryl group Chemical group 0.000 description 32
- 238000004587 chromatography analysis Methods 0.000 description 31
- 235000002639 sodium chloride Nutrition 0.000 description 31
- PURSZYWBIQIANP-UHFFFAOYSA-N 1-(bromomethyl)-2-chlorobenzene Chemical compound ClC1=CC=CC=C1CBr PURSZYWBIQIANP-UHFFFAOYSA-N 0.000 description 29
- 125000003118 aryl group Chemical group 0.000 description 29
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 29
- 229910000027 potassium carbonate Inorganic materials 0.000 description 28
- 239000000741 silica gel Substances 0.000 description 28
- 229910002027 silica gel Inorganic materials 0.000 description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 28
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 27
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 23
- 239000008346 aqueous phase Substances 0.000 description 21
- 239000000284 extract Substances 0.000 description 21
- 239000003921 oil Substances 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 239000012074 organic phase Substances 0.000 description 19
- 238000003756 stirring Methods 0.000 description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 18
- 229910052799 carbon Inorganic materials 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 18
- 239000002244 precipitate Substances 0.000 description 17
- 238000001914 filtration Methods 0.000 description 15
- 239000001257 hydrogen Substances 0.000 description 15
- 229910052739 hydrogen Inorganic materials 0.000 description 15
- 239000012258 stirred mixture Substances 0.000 description 15
- 239000010779 crude oil Substances 0.000 description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 14
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- GGIYCALCWUWLHT-UHFFFAOYSA-N n-(3-chloro-2-methylphenyl)-4,5-dihydro-1,3-thiazol-2-amine Chemical compound CC1=C(Cl)C=CC=C1NC1=NCCS1 GGIYCALCWUWLHT-UHFFFAOYSA-N 0.000 description 13
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000001953 recrystallisation Methods 0.000 description 12
- 239000012453 solvate Substances 0.000 description 12
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 11
- 230000003197 catalytic effect Effects 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 10
- 125000000753 cycloalkyl group Chemical group 0.000 description 10
- 239000012053 oil suspension Substances 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 10
- 125000000392 cycloalkenyl group Chemical group 0.000 description 9
- 238000003818 flash chromatography Methods 0.000 description 9
- 239000012299 nitrogen atmosphere Substances 0.000 description 9
- 238000002390 rotary evaporation Methods 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- UCQPLDQYPHTEMR-UHFFFAOYSA-N ethyl 4-hydroxy-6-oxo-3-propan-2-yl-1h-pyridazine-5-carboxylate Chemical compound CCOC(=O)C1=C(O)C(C(C)C)=NNC1=O UCQPLDQYPHTEMR-UHFFFAOYSA-N 0.000 description 8
- 150000007857 hydrazones Chemical class 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 206010021143 Hypoxia Diseases 0.000 description 7
- 239000000651 prodrug Substances 0.000 description 7
- 229940002612 prodrug Drugs 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 6
- SCZNXLWKYFICFV-UHFFFAOYSA-N 1,2,3,4,5,7,8,9-octahydropyrido[1,2-b]diazepine Chemical compound C1CCCNN2CCCC=C21 SCZNXLWKYFICFV-UHFFFAOYSA-N 0.000 description 6
- TXVVVEUSVBLDED-UHFFFAOYSA-N 1-(bromomethyl)-2-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1CBr TXVVVEUSVBLDED-UHFFFAOYSA-N 0.000 description 6
- QZNQSIHCDAGZIA-UHFFFAOYSA-N 1-(bromomethyl)-4-tert-butylbenzene Chemical compound CC(C)(C)C1=CC=C(CBr)C=C1 QZNQSIHCDAGZIA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 6
- 125000000304 alkynyl group Chemical group 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- KVSVNRFSKRFPIL-UHFFFAOYSA-N 1-(bromomethyl)-3,5-difluorobenzene Chemical compound FC1=CC(F)=CC(CBr)=C1 KVSVNRFSKRFPIL-UHFFFAOYSA-N 0.000 description 5
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- NSFJAFZHYOAMHL-UHFFFAOYSA-N (4-nitrophenyl)boronic acid Chemical compound OB(O)C1=CC=C([N+]([O-])=O)C=C1 NSFJAFZHYOAMHL-UHFFFAOYSA-N 0.000 description 4
- HZQLUIZFUXNFHK-UHFFFAOYSA-N 1-(bromomethyl)-4-phenylbenzene Chemical group C1=CC(CBr)=CC=C1C1=CC=CC=C1 HZQLUIZFUXNFHK-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- 125000005915 C6-C14 aryl group Chemical group 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- KWFADUNOPOSMIJ-UHFFFAOYSA-N ethyl 3-chloro-3-oxopropanoate Chemical compound CCOC(=O)CC(Cl)=O KWFADUNOPOSMIJ-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 3
- XGCDBGRZEKYHNV-UHFFFAOYSA-N 1,1-bis(diphenylphosphino)methane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CP(C=1C=CC=CC=1)C1=CC=CC=C1 XGCDBGRZEKYHNV-UHFFFAOYSA-N 0.000 description 3
- LOZSSHYLDBDYSQ-UHFFFAOYSA-N 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=NC(N2CCNCC2)=C1 LOZSSHYLDBDYSQ-UHFFFAOYSA-N 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 3
- IPOVOSHRRIJKBR-UHFFFAOYSA-N 2-ethylpropanedioyl dichloride Chemical compound CCC(C(Cl)=O)C(Cl)=O IPOVOSHRRIJKBR-UHFFFAOYSA-N 0.000 description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 3
- SIAVMDKGVRXFAX-UHFFFAOYSA-N 4-carboxyphenylboronic acid Chemical compound OB(O)C1=CC=C(C(O)=O)C=C1 SIAVMDKGVRXFAX-UHFFFAOYSA-N 0.000 description 3
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- MSJHOJKVMMEMNX-UHFFFAOYSA-N benzylhydrazine;hydron;dichloride Chemical compound Cl.Cl.NNCC1=CC=CC=C1 MSJHOJKVMMEMNX-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- JZRHODNPRNTXKO-UHFFFAOYSA-N cyclohexylhydrazine;hydrochloride Chemical compound Cl.NNC1CCCCC1 JZRHODNPRNTXKO-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- GOQQIBZDTDSGQA-UHFFFAOYSA-N ethyl 3-cyclohexyl-4-hydroxy-6-oxo-1h-pyridazine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=C(O)C(C2CCCCC2)=N1 GOQQIBZDTDSGQA-UHFFFAOYSA-N 0.000 description 3
- HCPOCMMGKBZWSJ-UHFFFAOYSA-N ethyl 3-hydrazinyl-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)NN HCPOCMMGKBZWSJ-UHFFFAOYSA-N 0.000 description 3
- CKTYYUQUWFEUCO-UHFFFAOYSA-N ethyl 3-methyl-2-oxobutanoate Chemical compound CCOC(=O)C(=O)C(C)C CKTYYUQUWFEUCO-UHFFFAOYSA-N 0.000 description 3
- OHTMYMLQNPNRJD-UHFFFAOYSA-N ethyl 4-hydroxy-6-oxo-3-phenyl-1h-pyridazine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=C(O)C(C=2C=CC=CC=2)=N1 OHTMYMLQNPNRJD-UHFFFAOYSA-N 0.000 description 3
- 229940117360 ethyl pyruvate Drugs 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 230000033444 hydroxylation Effects 0.000 description 3
- 238000005805 hydroxylation reaction Methods 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- FFWQLZFIMNTUCZ-UHFFFAOYSA-N 1-(bromomethyl)-2-fluorobenzene Chemical compound FC1=CC=CC=C1CBr FFWQLZFIMNTUCZ-UHFFFAOYSA-N 0.000 description 2
- WGVYCXYGPNNUQA-UHFFFAOYSA-N 1-(bromomethyl)-2-methylbenzene Chemical compound CC1=CC=CC=C1CBr WGVYCXYGPNNUQA-UHFFFAOYSA-N 0.000 description 2
- HXBMIQJOSHZCFX-UHFFFAOYSA-N 1-(bromomethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CBr HXBMIQJOSHZCFX-UHFFFAOYSA-N 0.000 description 2
- KVQXFNGVIIPCSX-UHFFFAOYSA-N 1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine Chemical compound C1CN(C)CCN1C1=CC=C(B2OC(C)(C)C(C)(C)O2)C=N1 KVQXFNGVIIPCSX-UHFFFAOYSA-N 0.000 description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 2
- HTFXWAOSQODIBI-UHFFFAOYSA-N 2-benzyl-1,3-dihydropyrrolo[3,4-c]pyridine Chemical compound C1C2=CC=NC=C2CN1CC1=CC=CC=C1 HTFXWAOSQODIBI-UHFFFAOYSA-N 0.000 description 2
- JRQAAYVLPPGEHT-UHFFFAOYSA-N 2-bromoethylcyclohexane Chemical compound BrCCC1CCCCC1 JRQAAYVLPPGEHT-UHFFFAOYSA-N 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- IAWVHZJZHDSEOC-UHFFFAOYSA-N 3,3-dimethyl-2-oxobutanoic acid Chemical compound CC(C)(C)C(=O)C(O)=O IAWVHZJZHDSEOC-UHFFFAOYSA-N 0.000 description 2
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 2
- XLWSBDFQAJXCQX-UHFFFAOYSA-N 4-(bromomethyl)-1,2-dichlorobenzene Chemical compound ClC1=CC=C(CBr)C=C1Cl XLWSBDFQAJXCQX-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 102000004662 Elongin Human genes 0.000 description 2
- 108010003751 Elongin Proteins 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 101000881678 Homo sapiens Prolyl hydroxylase EGLN3 Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102100037247 Prolyl hydroxylase EGLN3 Human genes 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000010437 erythropoiesis Effects 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- OBBCUYSNSIRXPX-UHFFFAOYSA-N ethyl 2-[(2-bromophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1Br OBBCUYSNSIRXPX-UHFFFAOYSA-N 0.000 description 2
- NYTKTLRAJUOELI-UHFFFAOYSA-N ethyl 2-[(3-bromophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C(C)C)=NN1CC1=CC=CC(Br)=C1 NYTKTLRAJUOELI-UHFFFAOYSA-N 0.000 description 2
- GSAAAXFPGWDPNJ-UHFFFAOYSA-N ethyl 2-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C(C)C)=NN1CC1=CC=C(C(F)(F)F)C=C1F GSAAAXFPGWDPNJ-UHFFFAOYSA-N 0.000 description 2
- MAOUXDYQHDQFFV-UHFFFAOYSA-N ethyl 2-cyclohexyl-2-oxoacetate Chemical compound CCOC(=O)C(=O)C1CCCCC1 MAOUXDYQHDQFFV-UHFFFAOYSA-N 0.000 description 2
- QXOWAJZWNQSEEW-QINSGFPZSA-N ethyl 3-[(2e)-2-(2-ethoxy-2-oxo-1-thiophen-2-ylethylidene)hydrazinyl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)N\N=C(/C(=O)OCC)C1=CC=CS1 QXOWAJZWNQSEEW-QINSGFPZSA-N 0.000 description 2
- HYVQFTYPJROWKW-UHFFFAOYSA-N ethyl 3-methyl-2-(2,2,2-trifluoroethylhydrazinylidene)butanoate Chemical compound CCOC(=O)C(C(C)C)=NNCC(F)(F)F HYVQFTYPJROWKW-UHFFFAOYSA-N 0.000 description 2
- ZBYZZRBZUZUILK-UHFFFAOYSA-N ethyl 5-hydroxy-3-oxo-6-propan-2-yl-2-(2,2,2-trifluoroethyl)pyridazine-4-carboxylate Chemical compound CCOC(=O)C1=C(O)C(C(C)C)=NN(CC(F)(F)F)C1=O ZBYZZRBZUZUILK-UHFFFAOYSA-N 0.000 description 2
- QKLCQKPAECHXCQ-UHFFFAOYSA-N ethyl phenylglyoxylate Chemical compound CCOC(=O)C(=O)C1=CC=CC=C1 QKLCQKPAECHXCQ-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 238000009491 slugging Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- DHQMUJSACXTPEA-UHFFFAOYSA-N (2-methoxypyridin-4-yl)boronic acid Chemical compound COC1=CC(B(O)O)=CC=N1 DHQMUJSACXTPEA-UHFFFAOYSA-N 0.000 description 1
- IVUHTLFKBDDICS-UHFFFAOYSA-N (4-methylsulfanylphenyl)boronic acid Chemical compound CSC1=CC=C(B(O)O)C=C1 IVUHTLFKBDDICS-UHFFFAOYSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- PVIGUZZDWGININ-UHFFFAOYSA-N 1-(bromomethyl)-2,3-dichlorobenzene Chemical compound ClC1=CC=CC(CBr)=C1Cl PVIGUZZDWGININ-UHFFFAOYSA-N 0.000 description 1
- IBLMYGXJKQIGSN-UHFFFAOYSA-N 1-(bromomethyl)-2,4-difluorobenzene Chemical compound FC1=CC=C(CBr)C(F)=C1 IBLMYGXJKQIGSN-UHFFFAOYSA-N 0.000 description 1
- MQUCRCQNRDHRPL-UHFFFAOYSA-N 1-(bromomethyl)-2-fluoro-4-(trifluoromethyl)benzene Chemical compound FC1=CC(C(F)(F)F)=CC=C1CBr MQUCRCQNRDHRPL-UHFFFAOYSA-N 0.000 description 1
- SEXZHJJUKFXNDY-UHFFFAOYSA-N 1-(bromomethyl)-2-phenylbenzene Chemical compound BrCC1=CC=CC=C1C1=CC=CC=C1 SEXZHJJUKFXNDY-UHFFFAOYSA-N 0.000 description 1
- RTFPTPXBTIUISM-UHFFFAOYSA-N 1-(bromomethyl)-3-phenylbenzene Chemical compound BrCC1=CC=CC(C=2C=CC=CC=2)=C1 RTFPTPXBTIUISM-UHFFFAOYSA-N 0.000 description 1
- IKSNDOVDVVPSMA-UHFFFAOYSA-N 1-(bromomethyl)-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(CBr)C=C1 IKSNDOVDVVPSMA-UHFFFAOYSA-N 0.000 description 1
- UFCSSWZQROEFBZ-UHFFFAOYSA-N 1-(bromomethyl)-4-chloro-2-fluorobenzene Chemical compound FC1=CC(Cl)=CC=C1CBr UFCSSWZQROEFBZ-UHFFFAOYSA-N 0.000 description 1
- JMNOONULDANZRZ-UHFFFAOYSA-N 1-(bromomethyl)-4-fluoro-2-(trifluoromethyl)benzene Chemical compound FC1=CC=C(CBr)C(C(F)(F)F)=C1 JMNOONULDANZRZ-UHFFFAOYSA-N 0.000 description 1
- NVNPLEPBDPJYRZ-UHFFFAOYSA-N 1-(bromomethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CBr)C=C1 NVNPLEPBDPJYRZ-UHFFFAOYSA-N 0.000 description 1
- AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 1
- LZSYGJNFCREHMD-UHFFFAOYSA-N 1-bromo-2-(bromomethyl)benzene Chemical compound BrCC1=CC=CC=C1Br LZSYGJNFCREHMD-UHFFFAOYSA-N 0.000 description 1
- ZPCJPJQUVRIILS-UHFFFAOYSA-N 1-bromo-3-(bromomethyl)benzene Chemical compound BrCC1=CC=CC(Br)=C1 ZPCJPJQUVRIILS-UHFFFAOYSA-N 0.000 description 1
- YLRBJYMANQKEAW-UHFFFAOYSA-N 1-bromo-4-(bromomethyl)benzene Chemical compound BrCC1=CC=C(Br)C=C1 YLRBJYMANQKEAW-UHFFFAOYSA-N 0.000 description 1
- XHCAGOVGSDHHNP-UHFFFAOYSA-N 1-bromo-4-tert-butylbenzene Chemical compound CC(C)(C)C1=CC=C(Br)C=C1 XHCAGOVGSDHHNP-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OPMFFAOEPFATTG-UHFFFAOYSA-N 2,2,2-trifluoroethylhydrazine Chemical compound NNCC(F)(F)F OPMFFAOEPFATTG-UHFFFAOYSA-N 0.000 description 1
- HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
- IRSVDHPYXFLLDS-UHFFFAOYSA-N 2,4-dichloro-1-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1Cl IRSVDHPYXFLLDS-UHFFFAOYSA-N 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical group CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- WFLCAOGKZQTOIG-UHFFFAOYSA-N 2-(bromomethyl)-1,3-benzothiazole Chemical compound C1=CC=C2SC(CBr)=NC2=C1 WFLCAOGKZQTOIG-UHFFFAOYSA-N 0.000 description 1
- PDFGFQUSSYSWNI-UHFFFAOYSA-N 2-(bromomethyl)-1,3-dichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1CBr PDFGFQUSSYSWNI-UHFFFAOYSA-N 0.000 description 1
- UUVDOPTUDWJHFK-UHFFFAOYSA-N 2-(bromomethyl)-1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C(CBr)=C1 UUVDOPTUDWJHFK-UHFFFAOYSA-N 0.000 description 1
- ONWGSWNHQZYCFK-UHFFFAOYSA-N 2-(bromomethyl)-1,4-difluorobenzene Chemical compound FC1=CC=C(F)C(CBr)=C1 ONWGSWNHQZYCFK-UHFFFAOYSA-N 0.000 description 1
- TZXVCSJGARFVLZ-UHFFFAOYSA-N 2-[[5-hydroxy-3-oxo-6-propan-2-yl-2-[[2-[4-(trifluoromethyl)phenyl]phenyl]methyl]pyridazine-4-carbonyl]amino]acetic acid Chemical compound O=C1C(C(=O)NCC(O)=O)=C(O)C(C(C)C)=NN1CC1=CC=CC=C1C1=CC=C(C(F)(F)F)C=C1 TZXVCSJGARFVLZ-UHFFFAOYSA-N 0.000 description 1
- RIYFONBSYWACFF-UHFFFAOYSA-N 2-bromoethylcyclopropane Chemical compound BrCCC1CC1 RIYFONBSYWACFF-UHFFFAOYSA-N 0.000 description 1
- LUNMJRJMSXZSLC-UHFFFAOYSA-N 2-cyclopropylethanol Chemical compound OCCC1CC1 LUNMJRJMSXZSLC-UHFFFAOYSA-N 0.000 description 1
- KVTHPKXDLVYNCH-UHFFFAOYSA-N 2-iodoethylbenzene Chemical compound ICCC1=CC=CC=C1 KVTHPKXDLVYNCH-UHFFFAOYSA-N 0.000 description 1
- GPVQDOZPSDGYPC-UHFFFAOYSA-N 2-iodoethylcyclopropane Chemical compound ICCC1CC1 GPVQDOZPSDGYPC-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- CVKOOKPNCVYHNY-UHFFFAOYSA-N 3-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC(C#N)=C1 CVKOOKPNCVYHNY-UHFFFAOYSA-N 0.000 description 1
- HVBSAKJJOYLTQU-UHFFFAOYSA-M 4-aminobenzenesulfonate Chemical compound NC1=CC=C(S([O-])(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-M 0.000 description 1
- XMHNLZXYPAULDF-UHFFFAOYSA-N 4-bromo-1-(bromomethyl)-2-fluorobenzene Chemical compound FC1=CC(Br)=CC=C1CBr XMHNLZXYPAULDF-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- CDEMHJCJMMOFMB-UHFFFAOYSA-M ClC1=CC=C([Mg]Br)C=C1 Chemical compound ClC1=CC=C([Mg]Br)C=C1 CDEMHJCJMMOFMB-UHFFFAOYSA-M 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 102100036448 Endothelial PAS domain-containing protein 1 Human genes 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 101000746072 Homo sapiens Cullin-2 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Chemical group 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
- 108700031765 Von Hippel-Lindau Tumor Suppressor Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- VCJZTATVUDMNLU-UHFFFAOYSA-N dibromomethylbenzene Chemical compound BrC(Br)C1=CC=CC=C1 VCJZTATVUDMNLU-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- DBKKFIIYQGGHJO-UHFFFAOYSA-N diethyl 2-oxopropanedioate Chemical compound CCOC(=O)C(=O)C(=O)OCC DBKKFIIYQGGHJO-UHFFFAOYSA-N 0.000 description 1
- GXEODMVGOVDWNZ-UHFFFAOYSA-N diethyl 4-hydroxy-6-oxo-1h-pyridazine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=NNC(=O)C(C(=O)OCC)=C1O GXEODMVGOVDWNZ-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 108010018033 endothelial PAS domain-containing protein 1 Proteins 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229950000206 estolate Drugs 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- WTPMFFQBDYIARF-UHFFFAOYSA-N ethyl 2-(1h-indol-3-yl)-2-oxoacetate Chemical compound C1=CC=C2C(C(=O)C(=O)OCC)=CNC2=C1 WTPMFFQBDYIARF-UHFFFAOYSA-N 0.000 description 1
- GFZVJNYHDPDRBS-UHFFFAOYSA-N ethyl 2-(2-cyclopropylethyl)-5-hydroxy-3-oxo-6-phenylpyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C=2C=CC=CC=2)=NN1CCC1CC1 GFZVJNYHDPDRBS-UHFFFAOYSA-N 0.000 description 1
- RFKIEIUHZZILBI-UHFFFAOYSA-N ethyl 2-(4-fluorophenyl)-2-oxoacetate Chemical compound CCOC(=O)C(=O)C1=CC=C(F)C=C1 RFKIEIUHZZILBI-UHFFFAOYSA-N 0.000 description 1
- BXHARDVKQMJAEM-UHFFFAOYSA-N ethyl 2-(cyclohexylhydrazinylidene)-3,3-dimethylbutanoate Chemical compound CCOC(=O)C(C(C)(C)C)=NNC1CCCCC1 BXHARDVKQMJAEM-UHFFFAOYSA-N 0.000 description 1
- DJMKTEXQYZVXGI-UHFFFAOYSA-N ethyl 2-(cyclohexylhydrazinylidene)-3-methylbutanoate Chemical compound CCOC(=O)C(C(C)C)=NNC1CCCCC1 DJMKTEXQYZVXGI-UHFFFAOYSA-N 0.000 description 1
- ALDQLNUNBAAUNX-UHFFFAOYSA-N ethyl 2-[(2-chlorophenyl)methyl]-5-hydroxy-3-oxo-6-phenylpyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C=2C=CC=CC=2)=NN1CC1=CC=CC=C1Cl ALDQLNUNBAAUNX-UHFFFAOYSA-N 0.000 description 1
- YGSVNVYMLFUZJQ-UHFFFAOYSA-N ethyl 2-[(2-chlorophenyl)methyl]-6-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C2CCCCC2)=NN1CC1=CC=CC=C1Cl YGSVNVYMLFUZJQ-UHFFFAOYSA-N 0.000 description 1
- IBBLCTUORFZRCO-UHFFFAOYSA-N ethyl 2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-3-oxo-6-propan-2-ylpyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C(C)C)=NN1CC1=CC=C(Br)C=C1F IBBLCTUORFZRCO-UHFFFAOYSA-N 0.000 description 1
- IFPBXJGIXOXNBM-UHFFFAOYSA-N ethyl 2-[(4-tert-butylphenyl)methyl]-6-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C2CCCCC2)=NN1CC1=CC=C(C(C)(C)C)C=C1 IFPBXJGIXOXNBM-UHFFFAOYSA-N 0.000 description 1
- CCZFSCAJHXPPPM-UHFFFAOYSA-N ethyl 2-benzyl-5-hydroxy-3-oxo-6-(trifluoromethyl)pyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C(F)(F)F)=NN1CC1=CC=CC=C1 CCZFSCAJHXPPPM-UHFFFAOYSA-N 0.000 description 1
- XEAUYKHVOSVDCF-UHFFFAOYSA-N ethyl 2-benzyl-6-cyclohexyl-5-hydroxy-3-oxopyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C2CCCCC2)=NN1CC1=CC=CC=C1 XEAUYKHVOSVDCF-UHFFFAOYSA-N 0.000 description 1
- GHOVLEQTRNXASK-UHFFFAOYSA-N ethyl 2-oxo-2-thiophen-2-ylacetate Chemical compound CCOC(=O)C(=O)C1=CC=CS1 GHOVLEQTRNXASK-UHFFFAOYSA-N 0.000 description 1
- MEUMAULWVAMIGS-UHFFFAOYSA-N ethyl 4-hydroxy-6-oxo-3-thiophen-2-yl-1h-pyridazine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=C(O)C(C=2SC=CC=2)=N1 MEUMAULWVAMIGS-UHFFFAOYSA-N 0.000 description 1
- ZNTUPPLZBOCGNW-UHFFFAOYSA-N ethyl 5-hydroxy-3-oxo-6-phenyl-2-(2-phenylethyl)pyridazine-4-carboxylate Chemical compound O=C1C(C(=O)OCC)=C(O)C(C=2C=CC=CC=2)=NN1CCC1=CC=CC=C1 ZNTUPPLZBOCGNW-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 102000056208 human CUL2 Human genes 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 125000005638 hydrazono group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- OTXBWGUYZNKPMG-UHFFFAOYSA-N isofulminic acid Chemical compound O[N+]#[C-] OTXBWGUYZNKPMG-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- XQNUHMQSOMLVGM-UHFFFAOYSA-M magnesium;1,3-difluorobenzene-5-ide;bromide Chemical compound [Mg+2].[Br-].FC1=C[C-]=CC(F)=C1 XQNUHMQSOMLVGM-UHFFFAOYSA-M 0.000 description 1
- GFTXWCQFWLOXAT-UHFFFAOYSA-M magnesium;cyclohexane;bromide Chemical compound [Mg+2].[Br-].C1CC[CH-]CC1 GFTXWCQFWLOXAT-UHFFFAOYSA-M 0.000 description 1
- BRKADVNLTRCLOW-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=[C-]C=C1 BRKADVNLTRCLOW-UHFFFAOYSA-M 0.000 description 1
- FCPRDUXJWIUVPZ-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=CC=[C-]1 FCPRDUXJWIUVPZ-UHFFFAOYSA-M 0.000 description 1
- FKUUDDGRDRPAQQ-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=C[C-]=C1 FKUUDDGRDRPAQQ-UHFFFAOYSA-M 0.000 description 1
- RBWRWAUAVRMBAC-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=[C-]C=C1 RBWRWAUAVRMBAC-UHFFFAOYSA-M 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- IZYBEMGNIUSSAX-UHFFFAOYSA-N methyl benzenecarboperoxoate Chemical compound COOC(=O)C1=CC=CC=C1 IZYBEMGNIUSSAX-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- LRMHVVPPGGOAJQ-UHFFFAOYSA-N methyl nitrate Chemical compound CO[N+]([O-])=O LRMHVVPPGGOAJQ-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- GADCWSZSMWEGDO-RESKGDFSSA-N n-[(2r,3r,4r,5s,6r)-2-[[(3ar,5r,5as,8as,8br)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydro-3ah-di[1,3]dioxolo[4,5-a:5',4'-d]pyran-5-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H]2OC(C)(C)O[C@@H]2[C@H]2OC(C)(C)O[C@H]2O1 GADCWSZSMWEGDO-RESKGDFSSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical compound CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- XSROQCDVUIHRSI-UHFFFAOYSA-N thietane Chemical compound C1CSC1 XSROQCDVUIHRSI-UHFFFAOYSA-N 0.000 description 1
- VOVUARRWDCVURC-UHFFFAOYSA-N thiirane Chemical group C1CS1 VOVUARRWDCVURC-UHFFFAOYSA-N 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88471007P | 2007-01-12 | 2007-01-12 | |
| US60/884,710 | 2007-01-12 | ||
| PCT/US2008/050833 WO2008089052A2 (en) | 2007-01-12 | 2008-01-11 | N-substituted glycine derivatives: hydroxylase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2675252A1 CA2675252A1 (en) | 2008-07-24 |
| CA2675252C true CA2675252C (en) | 2015-05-26 |
Family
ID=39636631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2675252A Active CA2675252C (en) | 2007-01-12 | 2008-01-11 | N-substituted glycine derivatives: hydroxylase inhibitors |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7608621B2 (enExample) |
| EP (2) | EP2889289B1 (enExample) |
| JP (1) | JP5313925B2 (enExample) |
| KR (1) | KR101458655B1 (enExample) |
| CN (1) | CN101626685B (enExample) |
| AR (1) | AR064878A1 (enExample) |
| AU (1) | AU2008206441B2 (enExample) |
| BR (1) | BRPI0806566A2 (enExample) |
| CA (1) | CA2675252C (enExample) |
| CL (1) | CL2008000066A1 (enExample) |
| DK (1) | DK2124565T3 (enExample) |
| EA (1) | EA017112B1 (enExample) |
| ES (2) | ES2614355T3 (enExample) |
| HR (1) | HRP20150119T1 (enExample) |
| MX (1) | MX2009007548A (enExample) |
| PL (1) | PL2124565T3 (enExample) |
| PT (1) | PT2124565E (enExample) |
| SI (1) | SI2124565T1 (enExample) |
| TW (1) | TW200845991A (enExample) |
| WO (1) | WO2008089052A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040672A1 (es) * | 2002-07-25 | 2005-04-13 | Glaxo Group Ltd | Forma de dosificacion farmaceutica multicomponenete, cuerpo apropiado para ser utilizado en la misma y procedimiento para prepararla |
| CN101212967A (zh) | 2005-05-10 | 2008-07-02 | 因塞特公司 | 吲哚胺2,3-双加氧酶调节剂及其用法 |
| ITMI20051085A1 (it) * | 2005-06-10 | 2006-12-11 | Acs Dobfar Spa | Metodo di purificazione del cefotetan |
| ES2540561T3 (es) | 2005-12-20 | 2015-07-10 | Incyte Corporation | N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa |
| US7588924B2 (en) | 2006-03-07 | 2009-09-15 | Procter & Gamble Company | Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase |
| AU2007265460B2 (en) | 2006-06-26 | 2011-03-03 | Akebia Therapeutics Inc. | Prolyl hydroxylase inhibitors and methods of use |
| CA2663057C (en) * | 2006-09-19 | 2015-12-08 | Incyte Corporation | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
| US8952160B2 (en) | 2008-01-11 | 2015-02-10 | Fibrogen, Inc. | Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity |
| WO2009100250A1 (en) | 2008-02-05 | 2009-08-13 | Fibrogen, Inc. | Chromene derivatives and use thereof as hif hydroxylase activity inhibitors |
| PT2294066E (pt) | 2008-04-28 | 2014-11-21 | Janssen Pharmaceutica Nv | Benzoimidazoles como inibidores da prolil-hidroxilase |
| CN104042611B (zh) | 2008-07-08 | 2019-05-14 | 因塞特控股公司 | 作为吲哚胺2,3-双加氧酶的抑制剂的1,2,5-噁二唑 |
| EP2334682B1 (en) | 2008-08-20 | 2017-10-04 | Fibrogen, Inc. | Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
| EP2326179A4 (en) * | 2008-08-25 | 2011-08-17 | Smithkline Beecham Corp | PROLYLHYDROXYLASEHEMMER |
| JP5631741B2 (ja) * | 2008-11-13 | 2014-11-26 | 日本農薬株式会社 | ピラジン誘導体類の製造方法及びその中間体類 |
| CN105037323A (zh) | 2008-11-14 | 2015-11-11 | 菲布罗根有限公司 | 作为hif羟化酶抑制剂的苯并噻喃衍生物 |
| DE102009004061A1 (de) * | 2009-01-08 | 2010-07-15 | Merck Patent Gmbh | Pyridazinonderivate |
| AR077417A1 (es) * | 2009-07-17 | 2011-08-24 | Japan Tobacco Inc | Compuesto triazolopiridina y su accion como inhibidor de prolil hidroxilasa o agente inductor de la produccion de eritropoyetina |
| WO2011048611A1 (en) * | 2009-10-07 | 2011-04-28 | Torrent Pharmaceuticals Limited | Novel fused pyridazine derivatives |
| RS54323B1 (sr) * | 2009-10-21 | 2016-02-29 | Daiichi Sankyo Company, Limited | Derivat 5-hidroksipirimidin-4-karboksamida |
| PH12012500788A1 (en) | 2009-11-06 | 2016-07-27 | Aerpio Therapeutics Inc | Compositions and methods for treating colitis |
| WO2011115687A2 (en) * | 2010-03-19 | 2011-09-22 | Northwestern University | Alkylated sp-b peptoid compounds and related lung surfactant compositions |
| CN103608346B (zh) | 2011-02-02 | 2016-06-15 | 菲布罗根有限公司 | 作为缺氧诱导因子(hif)羟化酶抑制剂的萘啶衍生物 |
| GB201102659D0 (en) | 2011-02-15 | 2011-03-30 | Isis Innovation | Assay |
| US8865748B2 (en) | 2011-06-06 | 2014-10-21 | Akebia Therapeutics Inc. | Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer |
| NO2686520T3 (enExample) | 2011-06-06 | 2018-03-17 | ||
| GB201113101D0 (en) | 2011-07-28 | 2011-09-14 | Isis Innovation | Assay |
| BR112014009910B1 (pt) | 2011-10-25 | 2020-06-30 | Janssen Pharmaceutica N.V. | sal di-hidrato de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico, composição farmacêuticae pomada tópica |
| IN2015DN01035A (enExample) | 2012-07-30 | 2015-06-26 | Taisho Pharmaceutical Co Ltd | |
| MY204336A (en) | 2013-06-13 | 2024-08-23 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| MY174254A (en) | 2013-11-08 | 2020-04-01 | Incyte Holdings Corp | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor |
| CN114890943A (zh) | 2013-11-15 | 2022-08-12 | 阿克比治疗有限公司 | {[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基}乙酸固体形式,组合物和用途 |
| EP3190104B1 (en) | 2014-09-02 | 2021-10-27 | Sunshine Lake Pharma Co., Ltd. | Quinolinone compound and use thereof |
| AU2016209126A1 (en) | 2015-01-23 | 2017-08-10 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| UA123308C2 (uk) | 2015-04-01 | 2021-03-17 | Екебіа Терапьютікс, Інк. | Композиції і способи для лікування анемії |
| CN105130888A (zh) * | 2015-10-09 | 2015-12-09 | 中国药科大学 | 炔基吡啶类脯氨酰羟化酶抑制剂、其制备方法和医药用途 |
| CA3001065A1 (en) | 2015-10-14 | 2017-04-20 | Xiaoxi WEI | Compositions and methods for reducing ice crystal formation |
| MX2020011845A (es) | 2018-05-09 | 2021-01-15 | Akebia Therapeutics Inc | Proceso para preparar acido 2-[[5-(3-clorofenil)-3-hidroxipiridina -2-carbonil]amino]acetico. |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
| WO2021127273A1 (en) * | 2019-12-20 | 2021-06-24 | Gb004, Inc. | 1 -((6-oxo-1,6-dihydropyridazin-4-yl)methyl)piperazine and 1 -((6-oxo-1,6-dihydropyrimidin-4-yl)methyl)piperazine derivatives as prolyl hydroxylase, hif-1 alpha and pgk modulators for use in treating inflammatory diseases, cancer or infections |
| WO2022179967A1 (en) | 2021-02-23 | 2022-09-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Vadadustat for treating covid-19 in a hospitalized subject |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650960B1 (de) | 1993-11-02 | 1997-03-05 | Hoechst Aktiengesellschaft | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
| NZ270267A (en) | 1993-12-30 | 1997-03-24 | Hoechst Ag | 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions |
| GB9507318D0 (en) * | 1995-04-07 | 1995-05-31 | Zeneca Ltd | Alpha substituted pyridazino quinoline compounds |
| US6972296B2 (en) * | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| US20030176317A1 (en) | 2001-12-06 | 2003-09-18 | Volkmar Guenzler-Pukall | Stabilization of hypoxia inducible factor (HIF) alpha |
| US6878709B2 (en) * | 2002-01-04 | 2005-04-12 | Schering Corporation | 3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| WO2003088917A2 (en) | 2002-04-19 | 2003-10-30 | Vertex Pharmaceuticals Incorporated | Regulation of tnf-alpha |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| US7718624B2 (en) | 2004-09-01 | 2010-05-18 | Sitkovsky Michail V | Modulation of immune response and inflammation by targeting hypoxia inducible factors |
| EP1655283A1 (en) | 2004-11-08 | 2006-05-10 | Evotec OAI AG | 11beta-HSD1 Inhibitors |
| JP5390184B2 (ja) * | 2005-06-06 | 2014-01-15 | ファイブローゲン、インコーポレーテッド | 貧血の改良された治療方法 |
| US20070293575A1 (en) | 2006-06-15 | 2007-12-20 | Fibrogen, Inc. | Compounds and methods for treatment of cancer-related anemia |
| US7713986B2 (en) | 2006-06-15 | 2010-05-11 | Fibrogen, Inc. | Compounds and methods for treatment of chemotherapy-induced anemia |
| WO2008013838A2 (en) | 2006-07-25 | 2008-01-31 | Cephalon, Inc. | Pyridizinone derivatives |
| US20090011051A1 (en) | 2006-09-28 | 2009-01-08 | Roth Mark B | Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds |
| WO2008073292A2 (en) | 2006-12-08 | 2008-06-19 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn) |
| EP2328586A2 (en) | 2008-05-20 | 2011-06-08 | Cephalon, Inc. | Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands |
-
2008
- 2008-01-10 TW TW097100936A patent/TW200845991A/zh unknown
- 2008-01-10 CL CL200800066A patent/CL2008000066A1/es unknown
- 2008-01-11 PL PL08727581T patent/PL2124565T3/pl unknown
- 2008-01-11 US US11/972,702 patent/US7608621B2/en not_active Ceased
- 2008-01-11 ES ES14196983.2T patent/ES2614355T3/es active Active
- 2008-01-11 EA EA200970680A patent/EA017112B1/ru not_active IP Right Cessation
- 2008-01-11 EP EP14196983.2A patent/EP2889289B1/en active Active
- 2008-01-11 MX MX2009007548A patent/MX2009007548A/es active IP Right Grant
- 2008-01-11 AU AU2008206441A patent/AU2008206441B2/en not_active Ceased
- 2008-01-11 HR HRP20150119TT patent/HRP20150119T1/hr unknown
- 2008-01-11 BR BRPI0806566-7A patent/BRPI0806566A2/pt not_active IP Right Cessation
- 2008-01-11 DK DK08727581.4T patent/DK2124565T3/en active
- 2008-01-11 CN CN2008800073024A patent/CN101626685B/zh not_active Expired - Fee Related
- 2008-01-11 PT PT08727581T patent/PT2124565E/pt unknown
- 2008-01-11 EP EP08727581.4A patent/EP2124565B1/en active Active
- 2008-01-11 ES ES08727581.4T patent/ES2528745T3/es active Active
- 2008-01-11 CA CA2675252A patent/CA2675252C/en active Active
- 2008-01-11 JP JP2009545699A patent/JP5313925B2/ja active Active
- 2008-01-11 KR KR1020097016748A patent/KR101458655B1/ko active Active
- 2008-01-11 WO PCT/US2008/050833 patent/WO2008089052A2/en not_active Ceased
- 2008-01-11 AR ARP080100143A patent/AR064878A1/es active IP Right Grant
- 2008-01-11 SI SI200831409T patent/SI2124565T1/sl unknown
-
2011
- 2011-10-26 US US13/281,965 patent/USRE44613E1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2124565B1 (en) | 2015-01-07 |
| KR20090101376A (ko) | 2009-09-25 |
| JP5313925B2 (ja) | 2013-10-09 |
| MX2009007548A (es) | 2009-07-22 |
| US20080214549A1 (en) | 2008-09-04 |
| USRE44613E1 (en) | 2013-11-26 |
| KR101458655B1 (ko) | 2014-11-05 |
| CN101626685A (zh) | 2010-01-13 |
| BRPI0806566A2 (pt) | 2014-05-06 |
| CL2008000066A1 (es) | 2008-08-01 |
| WO2008089052A3 (en) | 2008-09-18 |
| AU2008206441B2 (en) | 2014-06-19 |
| EP2124565A2 (en) | 2009-12-02 |
| EP2124565A4 (en) | 2011-06-29 |
| EA200970680A1 (ru) | 2010-02-26 |
| EA017112B1 (ru) | 2012-09-28 |
| CA2675252A1 (en) | 2008-07-24 |
| EP2889289A1 (en) | 2015-07-01 |
| AR064878A1 (es) | 2009-04-29 |
| CN101626685B (zh) | 2013-03-13 |
| PL2124565T3 (pl) | 2015-05-29 |
| JP2010515756A (ja) | 2010-05-13 |
| EP2889289B1 (en) | 2016-12-21 |
| US7608621B2 (en) | 2009-10-27 |
| ES2614355T3 (es) | 2017-05-30 |
| PT2124565E (pt) | 2015-03-26 |
| SI2124565T1 (sl) | 2015-04-30 |
| DK2124565T3 (en) | 2015-02-09 |
| TW200845991A (en) | 2008-12-01 |
| WO2008089052A2 (en) | 2008-07-24 |
| HRP20150119T1 (hr) | 2015-05-08 |
| ES2528745T3 (es) | 2015-02-12 |
| AU2008206441A1 (en) | 2008-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2675252C (en) | N-substituted glycine derivatives: hydroxylase inhibitors | |
| CN101505752B (zh) | 脯氨酸羟化酶抑制剂 | |
| US20080171756A1 (en) | N-Substituted Glycine Derivatives: Prolyl Hydroxylase Inhibitors | |
| US20100305133A1 (en) | Prolyl Hydroxylase Inhibitors | |
| US20110039895A1 (en) | Prolyl hydroxylase inhibitors | |
| US20110144167A1 (en) | Prolyl Hydroxylase Inhibitors | |
| US20110098324A1 (en) | Prolyl hydroxylase inhibitors | |
| AU2008329746A1 (en) | Prolyl hydroxylase inhibitors | |
| WO2010059549A1 (en) | Prolyl hydroxylase inhibitors | |
| WO2010059555A1 (en) | Prolyl hydroxylase inhibitors | |
| HK1130671B (en) | Prolyl hydroxylase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20130104 |